Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$96,040
-$116,607 QoQ
Shares Held
343
-57.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#828
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $974,991,922 across 23 Diagnostics & Research names. LH ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,138,968 | $309,172,862 | |
| 2 | GH |
Guardant Health, Inc.
|
1,999,178 | $299,936,673 | |
| 3 | ILMN |
Illumina, Inc.
|
575,799 | $101,242,737 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
155,264 | $81,737,179 | |
| 5 | RVTY |
Revvity, Inc.
|
386,871 | $43,043,266 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
67,690 | $33,937,056 | |
| 7 | TWST |
Twist Bioscience Corp
|
298,113 | $30,669,864 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
131,558 | $29,836,038 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,040 | 343 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $212,647 | 797 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $129,704 | 517 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $103,628 | 361 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $95,553 | 364 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $192,242 | 826 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $66,043 | 288 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $67,266 | 301 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $59,628 | 293 | Shares | Defined | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||